Commensal bacteria inhibit viral infections via a tryptophan metabolite

What happened

A study published in Nature Communications on 13 August 2026 reports that commensal bacteria inhibit viral infections via a tryptophan metabolite. The authors have filed a patent application covering the therapeutic use of ArAT-expressing bacteria and their metabolites in viral infections. The research received funding from NIH, Gilead Sciences, and other sources.

Why it matters

The findings suggest a novel antimicrobial mechanism and may support the development of new therapeutic strategies for viral infections, as indicated by the patent application.